If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAura Renew Acq Regulatory News (ARA)

Share Price Information for Aura Renew Acq (ARA)

Share Price is delayed by 15 minutes
Get Live Data
2.50    0.00 (0.00%)
Bid:
1.50
Ask:
3.50
Spread: 2.00 (133.333%)
Market Cap: £262.50k
ARA Live PriceLast checked at - London Stock Exchange

Intraday Aura Renew Acq Share Chart

Rule 8.3- ARDANA

28 Mar 2008 09:09

UBS Global Asset Management (UK)Ltd28 March 2008 FORM 8.3 DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE (Rule 8.3 of the Takeover Code) 1. KEY INFORMATION Name of person dealing (Note 1) UBS GLOBAL ASSET MANAGEMENT (UK) LTD Company dealt in ARDANA Class of relevant security to which the dealings being disclosed relate (Note 2) ORDINARY SHARES Date of dealing 27-MAR-2008 2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE (a) Interests and short positions (following dealing) in the class of relevantsecurity dealt in (Note 3) Long Short Number (%) Number (%) (1) Relevant securities 3,945,631.00 6.0239% .00 .0000% (2) Derivatives (other than options) 0% 0% (3) Options and agreements to purchase/sell 0% 0% Total 3,945,631.00 6.0239% .00 .0000% (b) Interests and short positions in relevant securities of the company, otherthan the class dealt in (Note 3) Class of relevant security: Long Short Number (%) Number (%) (1) Relevant securities 0% 0% (2) Derivatives (other than options) 0% 0% (3) Options and agreements to purchase/sell 0% 0% Total .00 .0000% .00 .0000% (c) Rights to subscribe (Note 3) Class of relevant security: Details 3. DEALINGS (Note 4) (a) Purchases and sales Purchase/sale Number of securities Price per unit (Note 5) SALE 50,000.00 £0.11 (b) Derivatives transactions (other than options) Product Long/short Number of Price per name, e.g. (Note 6) securities unit (Note 5)CFD (Note 7) (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying Product Writing, Number of Exercise Type, Expiry Option name,e.g. selling, securities price e.g. date money call purchasing, to which American, paid/ option varying the option European received etc. relates etc. per unit (Note 7) (Note 5) (ii) Exercising Product name, Number of Exercise price per unit e.g. call option securities (Note 5) (d) Other dealings (including new securities) (Note 4) Nature of transaction Details Price per unit (Note 8) (if applicable) (Note 5) 4. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the persondisclosing and any other person relating to the voting rights of any relevantsecurities under any option referred to on this form or relating to the votingrights or future acquisition or disposal of any relevant securities to which anyderivative referred to on this form is referenced. If none, this should bestated. .............................................................................. Is a Supplemental Form 8 attached? (Note 9) NO Date of disclosure 28-MAR-2008 Contact name KIRSTY LAHMAR Telephone number 020 7901 5887 If a connected EFM, name of offeree /offeror with which connected If a connected EFM, state nature of connection (Note 10) Notes The Notes on Form 8.3 can be viewed on the Takeover Panel's website atwww.thetakeoverpanel.org.uk This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
2nd May 20073:08 pmRNSBlocklisting Interim Review
4th Apr 20072:41 pmRNSHolding(s) in Company
21st Mar 20073:00 pmRNSHolding(s) in Company
19th Mar 20076:21 pmRNSHolding(s) in Company
13th Mar 200712:00 pmRNSHolding(s) in Company
28th Feb 20072:58 pmRNSVoting Rights
14th Feb 20077:00 amRNSResearch Update
13th Feb 20077:01 amRNSRe Agreement
21st Dec 20067:00 amRNSTotal Voting Rights
19th Dec 20067:01 amRNSProduct Launch
19th Dec 20067:01 amRNSResearch Update
19th Dec 20067:01 amRNSInterim Results
12th Dec 20067:01 amRNSNotice of Results
16th Nov 20067:01 amRNSProduct Launch
2nd Nov 20062:09 pmRNSBlocklisting Interim Review
20th Oct 20065:37 pmRNSHolding(s) in Company
19th Oct 20063:10 pmRNSHolding(s) in Company
16th Oct 20065:40 pmRNSHolding(s) in Company
13th Oct 200610:34 amRNSDirector/PDMR Shareholding
12th Oct 20061:33 pmRNSEGM Statement
12th Oct 20067:46 amRNSResult of Placing
11th Oct 20061:51 pmRNSAGM Statement
28th Sep 200611:16 amRNSAnnual Information Update
20th Sep 20067:03 amRNSIssue of Equity
13th Sep 200611:40 amRNSAnnual Report and Accounts
11th Sep 20067:01 amRNSResearch Update
7th Sep 20067:02 amRNSResearch Update
31st Aug 20067:01 amRNSUS Patent for Teverelix LA
29th Jun 20067:02 amRNSFinal Results
29th Jun 20067:01 amRNSNon-Executive Director
14th Jun 20064:44 pmRNSNotice of Results
16th May 20064:17 pmRNSHolding(s) in Company
12th May 200612:19 pmRNSHolding(s) in Company
3rd May 20063:26 pmRNSAdditional Listing
12th Apr 20067:01 amRNSResearch Update
17th Mar 20067:02 amRNSAppointment
16th Mar 20063:10 pmRNSHolding(s) in Company
14th Mar 20065:41 pmRNSHolding(s) in Company
31st Jan 20067:01 amRNSFDA Update
13th Dec 20057:00 amRNSInterim Results
9th Nov 20057:00 amRNSRe Agreement
31st Oct 20057:00 amRNSResearch Update
28th Oct 20059:47 amRNSHolding(s) in Company
5th Oct 20057:00 amRNSStriant Germany Launch
27th Sep 20051:31 pmRNSHolding(s) in Company
21st Sep 200512:30 pmRNSDirector/PDMR Shareholding
21st Sep 20057:00 amRNSResearch Update
30th Aug 20057:00 amRNSChange of Adviser
29th Jun 20057:00 amRNSFinal Results
17th Jun 20057:58 amRNSNon-executive appointment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.